mmCSM-PPI

mmCSM-PPI predicts the impact of single and multiple missense mutations on protein-protein interactions (PPIs) by estimating mutation-induced changes in binding affinity to support analysis of molecular mechanisms and disease-associated disruptions.


Key Features:

  • Scalability and effectiveness: Employs a scalable machine learning model to assess changes in protein-protein binding affinity caused by single and multiple missense mutations.
  • Expanded graph-based signatures: Uses expanded graph-based signatures to capture the physicochemical and geometrical properties of multiple wild-type residue environments.
  • Integration with substitution scores and dynamics terms: Incorporates substitution scores and dynamics terms derived from normal mode analysis for comprehensive assessment of mutation effects.
  • Performance metrics: Achieves Pearson's correlation up to 0.75 (RMSE 1.64 kcal/mol) under 10-fold cross-validation and Pearson's correlation 0.70 (RMSE 2.06 kcal/mol) on a non-redundant blind test set, outperforming existing methods.

Scientific Applications:

  • Disease mechanism analysis: Predicts how missense mutations affect PPI binding affinities to aid study of molecular bases of diseases linked to disrupted PPIs.
  • Therapeutic target identification: Supports identification of potential therapeutic targets by indicating mutation-induced changes in interaction strength.
  • Complex genetic studies: Evaluates effects of multiple concurrent missense mutations to inform analyses in complex genetic contexts.

Methodology:

Expanded graph-based signatures, machine learning models, and dynamics terms from normal mode analysis are used to predict changes in protein-protein binding affinity.

Topics

Details

Tool Type:
api, web application
Added:
10/10/2021
Last Updated:
11/24/2024

Operations

Publications

Rodrigues CHM, Pires DEV, Ascher DB. mmCSM-PPI: predicting the effects of multiple point mutations on protein–protein interactions. Nucleic Acids Research. 2021;49(W1):W417-W424. doi:10.1093/nar/gkab273. PMID:33893812. PMCID:PMC8262703.

PMID: 33893812
PMCID: PMC8262703
Funding: - Medical Research Council: MR/M026302/1 - Jack Brockhoff Foundation: JBF 4186 - National Health and Medical Research Council: GNT1174405

Documentation

Downloads